article thumbnail

Key Takeaways from J.P. Morgan’s 41st Annual Healthcare Conference?

Alpha Sense BI

Specifically, within the pharma and biotech sectors, there have been 22 deals announced so far in 2023 — again, a low number compared to the 70 made over the same period last year. Additionally, unprofitable biopharma, aka most biotech companies, is expected to invest $1.1

Biotech 96
article thumbnail

BCG & Hello Tomorrow Track Innovation in Deep Tech Using NetBase Quid

Netbasequid

In their paper on Deep Tech: The Great Wave of Innovation , BCG and Hello Tomorrow explain “what deep tech is, how it works, how different stakeholders can contribute to it, and how it can be harnessed for competitive advantage.” Want to know how many biotech companies have received private funding over the last ten years?

Biotech 98
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Know where your competitors are conducting clinical trials!

Sedulo

As leaders in competitive strategy consulting, serving the life sciences community for the last 17 years, Sedulo Group can help you: Build a comprehensive view of the current and future competitive landscape. Obtain details on competitor clinical trial locations. Assess and benchmark enrollment timing.

Biotech 52
article thumbnail

The Evolution of AI in Asset Management

Alpha Sense BI

As time goes on and more firms adopt AI tools, these capabilities will become even more essential to maintain a competitive advantage. Research shows that the AI in asset management market will grow at a staggering 34% CAGR through 2027. Artificial intelligence is the only way to do it.

article thumbnail

Venture Capital Trends and Outlook for 2024

Alpha Sense BI

Market Analysis : A valuable tool for conducting market research , as it can analyze large volumes of market data, predict market trends, analyze customer preferences, and provide a snapshot of the competitive landscape. Competition for fundraising will continue heating up among startup companies in 2024.

Capital 52
article thumbnail

Vaccine Development: What to Expect in 2023

Alpha Sense BI

Moderna and BioTech, the pharmaceuticals companies behind the Moderna vaccines for the COVID-19 virus, just announced a new treatment this past December that would greatly reduce the chances of death from melanoma — stirring up substantial interest in investors to funnel capital. a potential cure for skin cancer.

Biotech 96
article thumbnail

What to Know About Medicare Drug Price Negotiations

Alpha Sense BI

The 10 initial drugs were chosen based on certain criteria set out by Medicare: they must be sold in pharmacies, not have substantial generic competition , and have been on the market for at least nine to 13 years for more complex biotech drugs.